The Bookseller: Elsevier puts together free resource on coronavirus

The Bookseller: Elsevier puts together free resource on coronavirus. “Elsevier has set up an Information Centre on the newly emerged coronavirus featuring in the current outbreak in China, with free information in English and Mandarin. The resource is intended to help healthcare professionals, medical researchers and the public, bringing together content from Elsevier’s medical journals, textbooks and clinical experts, alongside resources from other information providers and major health organisations. The centre will be updated regularly with the most current research and evidence-based information available.”

News Medical: Genome reference database can help predict disease-linked gene variants more accurately

News Medical: Genome reference database can help predict disease-linked gene variants more accurately. “Most diseases have a genetic component. To better understand disease, researchers led by the Garvan Institute of Medical Research are analysing genetic information to determine what keeps us healthy. In a world first, the team has compiled a genome reference database of thousands of healthy older Australians, which has the potential to predict disease-linked gene variants more accurately than has been previously possible.”

National Library of Medicine: A New and Improved PubMed®

National Library of Medicine: A New and Improved PubMed® . “NLM’s PubMed has long been recognized as a critical resource for helping researchers, health care professionals, students, and the general public keep current with rapid advances in the life sciences. We are excited to introduce an updated version of PubMed that features an updated design and technology to improve the user experience.”

PLOS Blogs: PLOS Joins Other Publishers and Societies in Support of the Proposed White House Policy Regarding Federally Funded Research

PLOS Blogs: PLOS Joins Other Publishers and Societies in Support of the Proposed White House Policy Regarding Federally Funded Research. “A peer-reviewed article, whether published via an AAP signatory, or a signatory of this letter, is ultimately authored and peer-reviewed by the same research community. There is nothing, therefore, contained in your proposed policy that jeopardizes the quality and integrity of American research. This research will continue to be performed and peer-reviewed by the same people, to the same high standards as before — it will simply be disseminated for the benefit of the American people and the entire research community more cost-effectively, immediately, and openly.”

Health IT Analytics: FDA Makes Real-World Data Available on Google Cloud Platform

Health IT Analytics: FDA Makes Real-World Data Available on Google Cloud Platform. “The FDA’s MyStudies platform, a tool that aims to collect real-world data to improve clinical trials and advance medical research, is now available on Google Cloud Platform. Launched in November 2018, the MyStudies open-source technology platform supports drug, biologic, and device organizations as they collect and report real-world data for regulatory submissions.”

Science: FDA and NIH let clinical trial sponsors keep results secret and break the law

Science: FDA and NIH let clinical trial sponsors keep results secret and break the law. “Science examined more than 4700 trials whose results should have been posted on the NIH website ClinicalTrials.gov under the 2017 rule. Reporting rates by most large pharmaceutical companies and some universities have improved sharply, but performance by many other trial sponsors—including, ironically, NIH itself—was lackluster. Those sponsors, typically either the institution conducting a trial or its funder, must deposit results and other data within 1 year of completing a trial. But of 184 sponsor organizations with at least five trials due as of 25 September 2019, 30 companies, universities, or medical centers never met a single deadline.”